| Insurance Carrier | Facility/Professional | Modifier | Typical Low | Median | Typical High |
|---|
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab, includes infusion or injection, and post administration monitoring
| Insurance Carrier | Facility/Professional | Modifier | Typical Low | Median | Typical High |
|---|